Dixon, Eric P <br/><br/>
Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.  [electronic resource] 

 -  Journal of immunological methods  03 2017 
 - 35-41 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-7905 
<br/><br/><label>Standard No.: </label>10.1016/j.jim.2017.01.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--immunology<br/>Antigens, Neoplasm--immunology<br/>Biopsy<br/>Blotting, Western<br/>Cell Nucleus--enzymology<br/>Cervix Uteri--enzymology<br/>DNA Topoisomerases, Type II--immunology<br/>DNA-Binding Proteins--immunology<br/>Epitope Mapping--methods<br/>Epitopes<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Minichromosome Maintenance Complex Component 2--immunology<br/>Poly-ADP-Ribose Binding Proteins<br/>Predictive Value of Tests<br/>S Phase<br/>Severity of Illness Index<br/>Tissue Array Analysis--methods<br/>Uterine Cervical Dysplasia--diagnosis<br/>Uterine Cervical Neoplasms--diagnosis